Core Viewpoint - Tilray Brands, Inc. is launching a new limited-edition line of premium cannabis flower called BC Selects under its Broken Coast brand, emphasizing quality and unique phenotypes from its genetic library [1][6]. Product Launch - BC Selects will feature small-batch, non-irradiated cannabis flower selected for exceptional qualities, including dense cola structure and pronounced terpene profiles [2]. - The first strain, Sprits 26, offers a balanced hybrid experience with a THC content of 28–34% and a terpene content of 2–5%, showcasing dominant terpenes like nerolidol and caryophyllene [3]. - Alongside BC Selects, Broken Coast is also introducing a modern version of the iconic Blue Dream strain in various formats [5]. Brand Commitment - Broken Coast is dedicated to pushing the boundaries of craft cannabis by curating exceptional phenotypes and prioritizing quality over quantity [6]. - The brand's philosophy emphasizes a relentless pursuit of purity and quality, involving meticulous monitoring of growing conditions and adherence to strict protocols [8][9]. Company Overview - Tilray Brands operates globally, focusing on lifestyle and consumer packaged goods, with a mission to inspire joy through innovative products [10]. - The company supports over 40 brands across more than 20 countries, including cannabis offerings and craft beverages [10].

California lawmakers have passed sweeping legislation to crack down on hemp-derived THC products, tightening oversight of a booming gray market. https://t.co/qc4zk5PTDJ https://t.co/NPX5nkXj65 ...

WATCH: How Cheech & Chong Turned Their Legacy Into A $100 Million Cannabis Empire https://t.co/AHeq0exRih https://t.co/k6Ddroz7kr ...

Cannara Biotech Conference Summary Company Overview - **Company Name**: Cannara Biotech Inc. - **Stock Symbol**: LOVE (TSXV) - **Industry**: Canadian Cannabis - **Founded**: 2018 - **Headquarters**: Quebec, Canada - **Facilities**: Operates over 1.6 million square feet across two fully owned facilities in Quebec [2][5] Core Business and Market Position - Cannara Biotech is a vertically integrated cannabis company focused on producing premium-grade cannabis at scale, emphasizing profitability, innovation, and long-term value creation [2][4] - Currently the **seventh largest producer** in Canada by sales and **second largest** in Quebec, with a **12.8% market share** in Quebec, up from 9.7% a year ago [5][17] - Annualized production run rate is approximately **50,000 kilograms** (50 million grams) [5][6] Financial Performance - **Q3 2025**: Best quarterly financial results in the company's history - **Nine months of 2025**: - Net revenue: **$80 million** - Gross profit: **$32.7 million** - Gross margin: **41%**, with steady quarter-over-quarter increases [9][10] - Adjusted EBITDA: **$20.7 million** (26% of revenues) [10] - Net income: **$9.8 million**, a **53% increase** from the previous year [10] - **Cash Flow**: Generated **$17.2 million** in operating cash flow and **$12.3 million** in free cash flow in the first nine months of 2025 [11] Operational Highlights - Achieved a **26% increase** in capacity over the past year without additional capital costs [6][9] - Vertical integration allows full control over the cannabis supply chain, enhancing quality and efficiency [7][24] - Upcoming launch of a new vape category in Quebec, with **20% retail shelf space** already secured [8][17] Competitive Advantages - Strong operational platform with a focus on premium quality, scalable operations, and cost leadership [8][9] - Access to Quebec's low electricity rates of **$0.059 per kilowatt**, significantly lower than other provinces [26] - High barriers to entry in Quebec due to strict regulations on sales and marketing, allowing Cannara to thrive without heavy promotional activities [26][27] Strategic Initiatives - Plans for a **$10 million investment** in a new dedicated processing center to support growth and expand capacity to **100,000 kilograms** annually [16][24] - Focus on internal growth rather than external acquisitions, emphasizing operational discipline and quality [25][27] Market Trends and Outlook - The Canadian cannabis market is experiencing a shift, with a **41% surge** in estimated retail sales year-over-year, positioning Cannara as a leader in growth [16][17] - The company is well-prepared to meet unserved demand and capitalize on upcoming market opportunities, particularly in the vape segment [8][17] Conclusion - Cannara Biotech is positioned as a dominant player in the Canadian cannabis market, with a strong financial performance, operational efficiencies, and a clear growth strategy focused on quality and innovation [2][9][27]

Core Insights - Aurora Cannabis Inc. is recognized as one of the 12 best marijuana stocks to buy according to analysts [1] - The company, in collaboration with Copeia, has launched an English-language version of the Physician Experience Platform (PEP), which includes over 130 anonymized case studies on medicinal cannabis treatments [1][2] - PEP aims to provide healthcare professionals with access to peer-reviewed clinical insights and is initially available in several countries including Canada, the UK, and Australia [1][2] Company Developments - The PEP platform builds on a successful German launch in 2024 and is secured by a DocCheck login for verified physicians [2] - Aurora Cannabis operates in the global medicinal and consumer cannabis markets under various brands such as MedReleaf, CanniMed, Drift, and San Rafael '71 [2] - The company intends to create an international medical cannabis case study database for physicians to upload cases in the future [2]

Core Insights - Cronos Group Inc. reported $33.5 million in net revenue for Q2 2025, marking a 21% increase year over year driven by strong cannabis flower sales in Israel and international markets, consolidation of Cronos GrowCo, and improved Canadian extract sales [1][3] - Gross profit rose from $8.2 million in Q2 2024 to $14.5 million, while adjusted EBITDA increased by $12.7 million to $1.7 million [1] - Despite revenue growth, Cronos reported a net loss of $38.5 million [1] Financial Performance - Net revenue for Q2 2025: $33.5 million, a 21% increase year over year [1] - Gross profit increased from $8.2 million to $14.5 million [1] - Adjusted EBITDA climbed to $1.7 million from the previous year's figure [1] - Net loss reported at $38.5 million [1] Market Position and Strategy - PEACE NATURALS® remains Israel's leading cannabis brand, contributing to record sales [3] - Planned growth in flower capacity and strong global momentum are expected to address supply limitations in Canada [3] - Flower sales generated approximately $2.2 million for Cronos GrowCo [3] - The company maintains a robust balance sheet with $834 million in cash and no debt, supporting international growth and brand innovation [3]

Industry Overview - The Canadian cannabis sector is crucial for investors looking to tap into the expanding U.S. marijuana market, which generated over $33 billion in sales in 2024 and is projected to exceed $50 billion by 2030 due to increasing state-level legalization and consumer demand [1][3] - Recent discussions around federal reform and rescheduling cannabis could benefit Canadian companies with U.S. partnerships or expansion plans, making them attractive to investors [1][3] Company Highlights - **Tilray Brands, Inc. (TLRY)**: - Operates in cultivation, processing, and distribution across Canada, Europe, and the U.S., focusing on hemp-derived beverages and wellness products, reaching about 1,000 retail stores [5][7] - Reported annual revenue of approximately $821 million with a gross profit of around $240 million, but net income remains negative with losses exceeding $2 billion [7] - **Canopy Growth Corporation (CGC)**: - One of the largest cannabis companies in Canada, with a strong presence in the U.S. through brands and subsidiaries rather than direct dispensary ownership [8][10] - Achieved year-over-year revenue growth of about 9%, but gross margin fell to 25% from 35% a year earlier, indicating financial strain [10] - **Village Farms International, Inc. (VFF)**: - Transitioned from agricultural production to cannabis, operating one of the largest cannabis greenhouse facilities in Canada with over 2.2 million square feet [12][14] - Reported annual revenue of about $336 million, a 17% increase from the previous year, but posted a net loss of approximately $36 million [14] Strategic Focus - Tilray is diversifying through beverages and wellness products, while Canopy is focusing on cost-cutting and U.S. brand partnerships [15] - Village Farms emphasizes efficiency and international expansion, positioning itself as one of the lowest-cost producers in Canada [14][15] Market Outlook - The Canadian cannabis sector faces challenges from oversupply and regulatory uncertainty, but leading companies are adapting their strategies to remain competitive [15][16] - September 2025 is seen as a critical period for the sector, with investors closely monitoring earnings, cost controls, and expansion efforts [16]

Company Overview - Vireo Growth Inc. has commenced the sale of adult-use cannabis at all eight Green Goods® dispensaries in Minnesota as of September 16, 2025 [1][2] - The company has been operating in Minnesota's medical cannabis market since 2014, serving tens of thousands of patients [2][4] - Vireo aims to expand access, improve product quality, and support the transition to a sustainable adult-use market in Minnesota [2][4] Market Impact - The launch of the adult-use cannabis market in Minnesota, with a population of 5.7 million, is expected to drive strong organic revenue growth for Vireo [1][2] - Vireo is one of the state's licensed adult-use cannabis cultivators and retailers, positioning itself to benefit from the new market dynamics [2][4] Product Offering - Green Goods® dispensaries offer a comprehensive range of medical and adult-use cannabis products, including flower, pre-rolls, edibles, and beverages [3][4] - The dispensaries are strategically located in key areas such as Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester, and Woodbury [3] Leadership Commentary - Amber Shimpa, President of Vireo, expressed pride in making products available to all Minnesotans while maintaining commitment to medical patients [3] - Alexandra Breant, Head of Market in Minnesota, highlighted the significance of this milestone in expanding access and building community [3]

Core Insights - Glow Lifetech Corp is expanding its MOD™ and .decimal™ brands into the Saskatchewan cannabis retail market, marking a significant step in its national growth strategy [1][2][3] Expansion Strategy - The expansion into Saskatchewan follows successful entries into Ontario and New Brunswick, with the company securing 10 product listings in Saskatchewan, which will create a new long-term revenue stream [2][4] - The company aims to leverage its success in Ontario to scale its operations nationally in a disciplined manner [2][3] Commercial Momentum - The Saskatchewan expansion is part of a broader strategy that includes deepening penetration in Ontario while entering new provinces [4][5] - Recent commercial progress indicates strong momentum, with MOD™ being established among Ontario's leading oil brands [4][5] Business Model and Innovation - Glow Lifetech's disciplined growth strategy combines expanded retail distribution, new provincial launches, and ongoing product innovation, reinforcing the fundamentals of the business [5] - The company's scalable model positions it for sustainable growth and long-term value creation [5]

WATCH: How Cheech & Chong Turned Their Legacy Into A $100 Million Cannabis Empire https://t.co/uS8VzUu0Wq https://t.co/QN6qtN7Ird ...